Published in Int J Obes Relat Metab Disord on May 01, 1995
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab (2000) 2.27
Sympathetic activation in obese normotensive subjects. Hypertension (1995) 1.78
Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation (1998) 1.60
Consensus statement: medical management of acromegaly. Eur J Endocrinol (2005) 1.54
Guidelines for acromegaly management. J Clin Endocrinol Metab (2002) 1.48
Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab (1999) 1.46
Urinary free cortisol is unrelated to physiological changes in urine volume in healthy women. Clin Chem (2000) 1.46
Growth hormone in obesity. Int J Obes Relat Metab Disord (1999) 1.43
Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J Endocrinol (2002) 1.22
Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin). Clin Endocrinol (Oxf) (1990) 1.19
Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int (2003) 1.19
Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab (2006) 1.17
Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. Eur J Endocrinol (2001) 1.17
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways. Curr Cancer Drug Targets (2009) 1.10
Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur Neuropsychopharmacol (1997) 1.09
d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci U S A (1995) 1.07
Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis. Int J Obes Relat Metab Disord (1998) 1.06
The MAP kinase cascades are activated during post-ischemic liver reperfusion. FEBS Lett (1996) 1.02
Serum leptin levels in post-hepatitis liver cirrhosis. J Hepatol (2000) 1.00
Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary (2001) 1.00
Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver. FEBS Lett (1992) 1.00
D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord (2007) 0.99
Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol (2012) 0.96
Effect of an antiserotoninergic drug, metergoline, on the ACTH and cortisol response to insulin hypoglycemia and lysine-vasopressin in man. J Clin Endocrinol Metab (1976) 0.95
Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Eur Respir J (2011) 0.94
Inferior petrosal sinus sampling in the differential diagnosis of Cushing's syndrome: results of an Italian multicenter study. Eur J Endocrinol (2001) 0.94
Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer. Mod Pathol (1994) 0.93
[Benign solitary fibrous tumor of the pancreas: a rare location of extra-pleural fibrous tumor. Single case report and review of the literature]. Pathologica (2007) 0.91
Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radic Biol Med (1999) 0.91
Role of biological markers in the clinical outcome of colon cancer. Br J Cancer (2002) 0.90
Diagnosis and treatment of acromegaly complications. J Endocrinol Invest (2003) 0.90
p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival. Am J Clin Pathol (1996) 0.90
The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states. J Clin Endocrinol Metab (2000) 0.90
Spontaneous nocturnal growth hormone secretion in anorexia nervosa. J Clin Endocrinol Metab (1997) 0.89
Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man. Acta Endocrinol (Copenh) (1980) 0.89
Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients. J Clin Endocrinol Metab (1986) 0.89
Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer (1998) 0.88
The role of transbronchial lung biopsy for the diagnosis of diffuse drug-induced lung disease: a case series of 44 patients. Sarcoidosis Vasc Diffuse Lung Dis (2008) 0.88
Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients. Diabetes Obes Metab (2007) 0.88
Disruption of friend of GATA 2 gene (FOG-2) by a de novo t(8;10) chromosomal translocation is associated with heart defects and gonadal dysgenesis. Clin Genet (2007) 0.88
Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer (2000) 0.88
Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension (2001) 0.87
State-resolved reactivity of CH4(2nu3) on Pt(111) and Ni(111): effects of barrier height and transition state location. J Phys Chem A (2007) 0.87
Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. J Clin Endocrinol Metab (1997) 0.86
Cellular signalling after in vivo heat shock in the liver. Cell Biol Int (2000) 0.85
Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol Cell Endocrinol (2003) 0.85
Leptin activates Stat3, Stat1 and AP-1 in mouse adipose tissue. Mol Cell Endocrinol (2000) 0.84
Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding. Biopharm Drug Dispos (1995) 0.84
Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest (2000) 0.83
Radial artery compliance in young, obese, normotensive subjects. Hypertension (1995) 0.83
A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.83
The role of inflammation and infection in prostate cancer: Importance in prevention, diagnosis and treatment. Drugs Today (Barc) (2010) 0.83
Rationale for hospital-based rehabilitation in obesity with comorbidities. Eur J Phys Rehabil Med (2013) 0.83
Effects of gamma aminobutyric acid (GABA) and muscimol on endocrine pancreatic function in man. Metabolism (1982) 0.83
Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs. Br J Cancer (2008) 0.82
Rapid stimulation of mitogen-activated protein kinase of rat liver by prolactin. Biochem J (1994) 0.82
Isolation of stem/progenitor cells from normal lung tissue of adult humans. Cell Prolif (2009) 0.82
Effects of long-term antiepileptic therapy on the hypothalamic-pituitary axis in man. Epilepsia (1984) 0.82
The human POMC gene promoter: where do we stand? J Endocrinol Invest (2011) 0.82
Effect of reserpine on growth hormone response to insulin hypoglycaemia and to arginine infusion in normal subjects and hyperthyroid patients. J Endocrinol (1971) 0.82
Creatine kinase and creatine kinase-MB isoenzyme during and after exercise testing in normal and obese young people. Chest (1992) 0.82
State and activity of protein kinase C in postischemic reperfused liver. Exp Mol Pathol (1992) 0.81
Effect of octreotide on catecholamine plasma levels in patients with chromaffin cell tumors. Horm Res (1993) 0.81
Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome. J Endocrinol Invest (2003) 0.81
Measuring changes after multidisciplinary rehabilitation of obese individuals. J Endocrinol Invest (2012) 0.81
gamma-Aminobutyric acid- and benzodiazepine-binding sites in human anterior pituitary tissue. J Clin Endocrinol Metab (1982) 0.81
Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man. Eur J Clin Pharmacol (1984) 0.81
Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians. J Endocrinol Invest (2003) 0.81
Ghrelin stimulates adrenocorticotrophic hormone (ACTH) secretion by human ACTH-secreting pituitary adenomas in vitro. J Neuroendocrinol (2007) 0.80
Cathepsin-K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis (2010) 0.80
Four year treatment with a long acting somatostatin analogue in a patient with Verner-Morrison syndrome. J Endocrinol Invest (1991) 0.80
Sam68 and ERKs regulate leptin-induced expression of OB-Rb mRNA in C2C12 myotubes. Mol Cell Endocrinol (2009) 0.80
Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone. J Clin Endocrinol Metab (1980) 0.80
Depression in the Italian community: epidemiology and socio-economic implications. Int Clin Psychopharmacol (2004) 0.80
Cushing's syndrome in pregnancy. J Endocrinol Invest (2003) 0.80
Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD). J Endocrinol Invest (2003) 0.80
Diagnostic role of rapid on-site cytologic examination (ROSE) of broncho-alveolar lavage in ALI/ARDS. Pathologica (2012) 0.80
Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome. Metabolism (1998) 0.80
Impairment of growth hormone and insulin secretion in hyperthyroidism. Eur J Clin Invest (1974) 0.80
Hyperthermia induces gene expression of heat shock protein 70 and phosphorylation of mitogen activated protein kinases in the rat cerebellum. Neurosci Lett (2001) 0.80
Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa. J Clin Endocrinol Metab (2000) 0.80
Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies: Part II. Int J Clin Pharmacol Ther Toxicol (1983) 0.79
Common principles in the biosynthesis of diverse enzymes. Biochem Soc Trans (2005) 0.79
Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I. Int J Clin Pharmacol Ther Toxicol (1983) 0.79
Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients. J Endocrinol (1972) 0.79